Technology Offerings

Innovative Sphingolipid Modulators for Multiple Sclerosis Treatment

The new modulators of sphingolipid signaling enable the treatment of relapsing-remitting multiple sclerosis.

Further Information: PDF

INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0

Contact
Dr. Otmar Schöller

Comments (0)

Write a comment